1094101-40-2

Upstream product

• 1094101-24-2 4-iodophenyl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate 
• 40243-87-6 3,5-dimethoxystyrene 
• 537-42-8 3,5-dimethoxy-4'-hydroxy-trans-stilbene 
• 65178-90-7 2-[4-(4-chlorobenzoyl)-phenoxy]-2-methylpropionyl chloride 
• 42017-89-0 fenofibric acid 

Relevant academic research and scientific papers

Novel Fenofibric Acid Prodrugs with Improved Bioavailability

The present invention relates to a novel fenofibric acid prodrug having improved bioavailability. According to the present invention, the fenofibric acid prodrug of the present invention shows higher bioavailability than existing fenofibric acid. Therefore, the fenofibric acid prodrug of the present invention can be developed as an effective therapeutic agent for treating hyperlipemia or the like.COPYRIGHT KIPO 2017

COMPOSITIONS AND METHODS OF USE FOR TREATING OR PREVENTING LIPID RELATED DISORDERS

Disclosed herein are novel compositions and methods for treating or preventing a variety of disorders and conditions associated with lipid metabolism. The methods generally include administering to a patient in need thereof a therapeutically effective amount of a pharmaceutical composition comprising one or more fibric acid or statin derivative compositions alone or in combination with one or more lipid altering agents and/or PDE inhibitors.